Alps Advisors Inc Exact Sciences Corp Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$56.04 - $82.66 $228,419 - $336,922	-4,076 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$48.29 - $80.6 $3,766 - $6,286	78 Added 1.95%	4,076 $322,000
Q2 2018 Jul 25, 2018	BUY	$37.84 - $69.96 $151,284 - $279,700	3,998 New	3,998 $210,000
Q1 2018 May 01, 2018	SELL	$39.82 - $57.53 $159,200 - $230,004	-3,998 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$46.49 - $60.51 $185,867 - $241,918	3,998	3,998 $210,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.